BankChampaign National Association’s AbbVie ABBV Stock Holding History

BankChampaign National Association’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$532K	Buy	2,116 +1,186	+128%	+$255K	0.41%	83
2026 Q1	$202K	Sell	930 -407	-30%	-$90.3K	0.2%	137
2025 Q4	$305K	Buy	+1,337	New	+$305K	0.3%	112

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BankChampaign National Association's ABBV Position: Q2 2026 in Review

BankChampaign National Association increased its AbbVie (ABBV) stake by 128% in Q2 2026, buying an estimated $255K and bringing the position to 2,116 shares worth $532K. The position accounts for 0.41% of the portfolio, ranked #83.

BankChampaign National Association first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

BankChampaign National Association held 2,116 shares of AbbVie worth $532K as of Q2 2026.
BankChampaign National Association bought 1,186 AbbVie shares in Q2 2026, an estimated $255K.
AbbVie made up 0.41% of BankChampaign National Association's portfolio in Q2 2026, its #83 holding.
BankChampaign National Association first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
4,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BankChampaign National Association's 13F filing for Q2 2026, filed 23 Jul 2026.